Roche Holding AG

Swiss Stock Exchange:RO.SW

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

🩺 Medical Instruments

Location

Switzerland

Market Cap

USD 260.52 B

Share Price

USD 341.12

Avg Daily Volume

39,406

Change (1 day)

-1.04%

Change (1 year)

9.96%

Change (YTD)

14.01%

Roche Holding AG Debt to Equity Ratio for the year ending December 31, 2024: 1.14

Roche Holding AG Debt to Equity Ratio is 1.14 for the year ending December 31, 2024, a 8.99% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Roche Holding AG Debt to Equity Ratio for the year ending December 31, 2023 was 1.05, a 10.73% change year over year.
Roche Holding AG Debt to Equity Ratio for the year ending December 31, 2022 was 0.95, a -28.66% change year over year.
Roche Holding AG Debt to Equity Ratio for the year ending December 31, 2021 was 1.33, a 213.45% change year over year.
Roche Holding AG Debt to Equity Ratio for the year ending December 31, 2020 was 0.42, a -10.88% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Debt to Equity Ratio	Quick Ratio	Current Ratio	Interest Coverage Ratio

Swiss Stock Exchange: RO.SW

Roche Holding AG

CEO	Dr. Thomas Schinecker
IPO Date	Aug. 3, 1995
Location	Switzerland
Headquarters	Konzern Hauptsitz
Employees	103,249
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 🩺 Medical Instruments

Description

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.